Infectious Diseases Propel Growth Of The Nucleic Acid Amplification Testing Market Driver: A Major Catalyst in the Evolution of the Nucleic Acid Amplification Testing Market in 2025

How Is the Nucleic Acid Amplification Testing Market Projected to Grow, and What Is Its Market Size?
In recent years, the market size for nucleic acid amplification testing has seen substantial growth. It is expected to expand from $9.56 billion in 2024 to $11.03 billion in 2025, with a compound annual growth rate (CAGR) of 15.3%. The previous period's growth can be attributed to factors like increased awareness about diagnosing infectious diseases, emergence of new pathogens, a move towards personalized medicine, the need for point-of-care testing, and regulatory approvals and guidelines.

Expectations indicate rapid expansion for the nucleic acid amplification testing market in the coming years, with forecasts predicting a growth to $19.26 billion by 2029, displaying a compound annual growth rate (CAGR) of 15.0%. Multiple factors can be associated with this rise such as, the escalating prevalence of infectious diseases, the necessity for expansive testing capacities, enhanced investment from private sectors, the rising demand for quick, precise testing methods, and a growing appetite for innovative diagnostic tools. In addition, major trends that are expected to impact this growth during the forecast period consist of advancements such as artificial intelligence (AI) integration, wearable and implantable devices development, increased popularity for point-of-care testing, personalized medicine evolution, and the amalgamation with digital health technologies.

What Are the Key Drivers Behind the Growth of the Nucleic Acid Amplification Testing Market?
The growth of the nucleic acid amplification testing market is set to be spurred on by a rising rate of infectious diseases. These diseases, which are the result of harmful organisms that can be spread from person to person either directly or indirectly via various methods such as touch, the air, food, water or insect-borne transmission, have seen an increased prevalence due to antibiotic resistance, changes in human behaviour, climate change and agriculture. Nucleic acid amplification testing, or NAAT, offers a quick and accurate way of identifying the infectious pathogens, which brings about a swift diagnosis and treatment that aids in preventing disease spread. As an example, in the 2022-2023 season, the Public Health Agency of Canada recorded 4,216 hospitalizations linked to influenza in the participating provinces and territories during October 2023. Thus, the nucleic acid amplification testing market's growth is boosted by the rising occurrence of infectious diseases.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19619&type=smp

Who Are the Major Industry Players Fueling Nucleic Acid Amplification Testing Market Expansion?
Major companies operating in the nucleic acid amplification testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., Cepheid Inc., GenScript Biotech Corporation, ARUP Laboratories, BGI Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc., Eiken Chemical Co. Ltd., New England Biolabs Inc., TwistDx Limited, Bioneer Corporation

Which Key Developments Are Influencing the Nucleic Acid Amplification Testing Market?
Leading firms in the nucleic acid amplification testing market are striving to create groundbreaking solutions, such as in vitro diagnostics (IVD) assays for CMV screening in donated blood utilizing nucleic acid amplification technology (NAT) as per the IVDR. An IVD assay refers to a test conducted on biological samples to identify diseases, conditions, or infections in a laboratory environment outside the body. For example, in June 2024, GFE, a company based in Germany, introduced the PoET CMV. The PoET CMV, an IVD assay, is specifically developed for quick and accurate detection of cytomegalovirus (CMV) infections. It possesses distinctive properties, primarily its high sensitivity and specificity, which facilitate early detection and efficient monitoring of CMV in transplant patients and those with compromised immune systems. The assay employs sophisticated molecular techniques to yield dependable results swiftly, aiding in making prompt clinical decisions.

How Is the Segmentation of the Nucleic Acid Amplification Testing Market Defined?
The nucleic acid amplification testingmarket covered in this report is segmented -

1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Product Type: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users

Subsegments:
1) By Target Amplification Systems: Polymerase Chain Reaction (PCR), Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Nested PCR, Multiplex PCR, LAMP (Loop-Mediated Isothermal Amplification),
2) By Probe Amplification Systems: Nucleic Acid Sequence-Based Amplification (NASBA), Hybridization-Based Amplification, Branch Chain Amplification (BCA), Strand Displacement Amplification (SDA),
3) By Signal Amplification Systems: Enzyme-Linked Signal Amplification, Fluorescent Signal Amplification, Chemiluminescent Signal Amplification, Electrochemical Signal Amplification, Magnetic Particle-Based Signal Amplification

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/nucleic-acid-amplification-testing-global-market-report

What Is the Leading Region in the Nucleic Acid Amplification Testing Market?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid amplification testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Nucleic Acid Amplification Testing Global Market Report?

- Market Size Analysis: Analyze the Nucleic Acid Amplification Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Nucleic Acid Amplification Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Nucleic Acid Amplification Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Nucleic Acid Amplification Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19619

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.